CD38 and myelodysplastic syndrome: Linde M. Morsink et al. reported that in 18 MDS-EB1/2 patients and the remaining 28 MDS patients, there was no significant difference in overall CLL-1 expression on CD34 + CD38- cells compared with that in the control group (p = 0.50).